We are live on ! Find out more
PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

3 hedge funds and large institutions have $177K invested in Progenics Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 129 → 3 (-126)

100% less capital invested

Capital invested by funds: $222M → $177K (-$222M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 126

Holders
3
Holders Change
-126
Holders Change %
-97.67%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
126
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$52.6M
2
FCM
Farallon Capital Management
California
-$31.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$21.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.3M
5
State Street
State Street
Massachusetts
-$17.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
– -$116K -30,577 Closed
MSA
77
Mason Street Advisors
Wisconsin
– -$114K -30,101 Closed
Deutsche Bank
78
Deutsche Bank
Germany
– -$114K -30,034 Closed
JP Morgan Chase
79
JP Morgan Chase
New York
– -$110K -29,048 Closed
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
– -$106K -27,938 Closed
MERSOM
81
Municipal Employees' Retirement System of Michigan
Michigan
– -$100K -26,200 Closed
UBS Group
82
UBS Group
Switzerland
– -$95K -25,005 Closed
BFM
83
Boothbay Fund Management
New York
– -$92K -24,144 Closed
LSERS
84
Louisiana State Employees Retirement System
Louisiana
– -$91K -23,850 Closed
FTCM
85
First Trust Capital Management
Illinois
– -$85K -22,293 Closed
Victory Capital Management
86
Victory Capital Management
Texas
– -$78K -20,706 Closed
ASRS
87
Arizona State Retirement System
Arizona
– -$77K -20,289 Closed
MFG
88
Magnus Financial Group
New York
– -$73K -19,140 Closed
MF
89
Magnetar Financial
Illinois
– -$71K -18,811 Closed
Lazard Asset Management
90
Lazard Asset Management
New York
– -$70K -18,440 Closed
ProShare Advisors
91
ProShare Advisors
Maryland
– -$70K -18,385 Closed
SG Americas Securities
92
SG Americas Securities
New York
– -$68K -17,931 Closed
Squarepoint
93
Squarepoint
New York
– -$68K -17,779 Closed
PAM
94
Panagora Asset Management
Massachusetts
– -$67K -17,512 Closed
TRSOTSOK
95
Teachers Retirement System of the State of Kentucky
Kentucky
– -$66K -17,400 Closed
AG
96
Aperio Group
California
– -$65K -17,170 Closed
AB
97
Amalgamated Bank
New York
– -$62K -16,298 Closed
DTL
98
Dynamic Technology Lab
Singapore
– -$55K -14,421 Closed
LPL Financial
99
LPL Financial
California
– -$50K -13,124 Closed
KBC Group
100
KBC Group
Belgium
– -$48K -12,732 Closed
1 2 3
4
5

PGNX Hedge Fund Activity: Q2 2020 in Review

3 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q2 2020, worth a combined $177K — down 100% from $222M a quarter earlier.

Sellers outnumbered buyers: 126 funds closed out of PGNX and 0 opened new positions — a net loss of 126 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $52.6M sold.

  • 3 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q2 2020, down from 129 in Q1 2020.
  • Funds reported $177K of Progenics Pharmaceuticals Inc stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Progenics Pharmaceuticals Inc positions in Q2 2020 and 126 closed out, a net change of -126 holders.
  • The largest Progenics Pharmaceuticals Inc seller in Q2 2020 was BlackRock, an estimated $52.6M sold.

Based on aggregated 13F filings for Q2 2020.